NCT00051974 2008-02-11Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung CancerMillennium Pharmaceuticals, Inc.Phase 2 Completed155 enrolled